RV144 Trial

The RV144 trial was a large study conducted in Thailand to test an experimental HIV vaccine. Researchers wanted to see if the vaccine could prevent HIV infection. They gave the vaccine to some volunteers and compared their outcomes to a control group that didn’t receive it. The study found a modest 31% reduction in HIV risk among vaccinated individuals, providing valuable insights into potential ways to develop an effective HIV vaccine. Although not a complete solution, it was an important step forward in HIV research, helping scientists understand how vaccines might protect people from the virus.